News

Activation Capital $15,000 Pitch Contest in November to Shine Light on Virginia Businesses

The inaugural Pitch Virginia event, powered by Activation Capital, will take place on Wednesday, November 10 at the newly opened Shift Retail Lab at VCU, an initiative of the VCU da Vinci Center.  Kicking off with a design thinking workshop in the morning, the day will be filled with pitches from high growth, main street and student companies competing for $15,000 of prize money, concluding with the grand opening event of the Shift Retail Lab at VCU with a cocktail networking event and open house tours of the space in the evening.  These events are an official activity of Global Entrepreneurship Week, an international movement to empower entrepreneurs and help make it possible for anyone, anywhere to start and scale.

Pitch Virginia is an opportunity to highlight the entrepreneurs and startup companies in the Commonwealth.  The contest will feature three categories: high growth startups, main street companies, and student-owned ventures.  Capital One is sponsoring the event and donated $15,000 in cash prizes for winning companies.

Matt Briggs, VP of Capital One Card Technology and Platforms shared, “Capital One is committed to elevating the mission driven small business ecosystem in Virginia and our support for this event allows us to empower entrepreneurs at all levels – student entrepreneurs, brick and mortar businesses, and high growth startups with the potential to scale. We are looking forward to November and Pitch Virginia to bring innovative minds and ecosystem supporters together to continue developing Virginia’s small business sector.”

Speaking about Pitch Virginia, Chandra Briggman, President and CEO of Activation Capital said, “We wanted to create a new event that will cater to founders and entrepreneurs, showcasing all types of companies, and feel Pitch Virginia will be a place for people to come together for networking and community, while also supporting the entrepreneurial ecosystem in the Commonwealth.”

Companies can apply to pitch and individuals can register to attend at http://activation.capital/pitch.

Recent News

05/22/2026

BIO Statement on Veto of Prescription Drug Affordability Boards (PDAB) in VirginiaPatrick J. Plues, Senior Vice President of State Government Affairs & Affiliate Relations at the Biotechnology Innovation Organization (BIO) released the following statement on the veto of Prescription Drug Affordability Boards (PDAB) legislation in Virginia: “BIO applauds Governor Spanberger’s decision to veto SB 271 and HB 483 — legislation that would have established a Prescription Drug Affordability Board (PDAB) and imposed arbitrary price controls in Virginia. The Governor’s action recognized an important point: even well-intentioned healthcare policies must be carefully designed to avoid unintended consequences for patients, providers, employers, and Virginia’s innovation economy. “BIO is proud to represent biotechnology companies developing the next generation of life-changing medicines, including many in the Commonwealth. We believe policymakers play a critically important role in helping advance both patient access to treatments and the continued growth of the life sciences sector. “We look forward to working with the Governor’s Administration, the General Assembly, Virginia Bio and other stakeholders to advance practical, patient-centered policy solutions that improve affordability while preserving access to care and the innovation ecosystem patients depend on.”

Patrick J. Plues, Senior Vice President of State Government Affairs & Affiliate Relations at the Biotechnology Innovation Organization (BIO) released the following statement on the veto of Prescription Drug Affordability Boards (PDAB) legislation in Virginia: “BIO applauds Governor Spanberger’s decision to veto SB 271 and HB 483 — legislation that would have established a Prescription

05/21/2026

Virginia Bio Applauds Governor Spanberger’s Veto of SB 271 and HB 483

The Virginia Biotechnology Association (Virginia Bio) today expressed strong support for Governor Abigail Spanberger’s decision to veto Senate Bill 271 and House Bill 483, legislation that would have established a Prescription Drug Affordability Advisory Panel (PDAAP) in the Commonwealth. Virginia Bio and the Virginia Chamber of Commerce sent a joint letter to Governor Spanberger commending

05/21/2026

New Global Clinical Society to Bring Focused Ultrasound Into Mainstream Medicine

The Focused Ultrasound Foundation today announced the launch of the International Focused Ultrasound Society (IFUS), a new organization dedicated to advancing clinical practice and accelerating adoption of focused ultrasound – a revolutionary, noninvasive therapeutic technology. Established as a program of the Focused Ultrasound Foundation, IFUS aggregates and expands the Foundation’s activities related to clinical implementation